APA (7th ed.) Citation

M, W., S, H., A, T., S, G., P, K., TK, T., . . . R, W. (2026). A next-generation episignature for Kabuki syndrome enables fine mapping of the impact of KMT2D variants to inform precision medicine. American journal of human genetics, 113(6), 1233. https://doi.org/10.1016/j.ajhg.2026.04.010

Chicago Style (17th ed.) Citation

M, Wang, et al. "A Next-generation Episignature for Kabuki Syndrome Enables Fine Mapping of the Impact of KMT2D Variants to Inform Precision Medicine." American Journal of Human Genetics 113, no. 6 (2026): 1233. https://doi.org/10.1016/j.ajhg.2026.04.010.

MLA (9th ed.) Citation

M, Wang, et al. "A Next-generation Episignature for Kabuki Syndrome Enables Fine Mapping of the Impact of KMT2D Variants to Inform Precision Medicine." American Journal of Human Genetics, vol. 113, no. 6, 2026, p. 1233, https://doi.org/10.1016/j.ajhg.2026.04.010.